Tether’s brand new venture capital division Tether Evo has completed a $200 million strategic investment in the neural implant firm.On April 29, Tether announced a strategic investment of $200 million into Blackrock Neurotech, becoming the majority stakeholder in the neural implant company. The investment was carried out through Tether Evo, a brand-new venture capital division at Tether.
The firm is committed to helping millions of people around the world afflicted with paralysis, lost function and neurological disorders that prevent them from walking, seeing, hearing, feeling, or talking. In 2016, Blackrock Neurotech’s patient Nathan Copeland made headlines when he used his Blackrock BCI to control a robotic arm and fist bump U.S. President Barack Obama.
Tether’s $200 million investment aims to fund the commercialization and the rollout of medical solutions that have already been successfully applied to more than 40 individuals. The investment will also be used to improve Blackrock Neurotech’s research and development and maintain its position as a major BCI player in the future, with a long-term focus on human evolution.
ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว
Similar News:คุณยังสามารถอ่านข่าวที่คล้ายกันนี้ซึ่งเรารวบรวมจากแหล่งข่าวอื่น ๆ ได้
แหล่ง: NBCLA - 🏆 319. / 59 อ่านเพิ่มเติม »